» Articles » PMID: 11958660

Morphologic Criteria for the Diagnosis of Prostatic Adenocarcinoma in Needle Biopsy Specimens. A Study of 250 Consecutive Cases in a Routine Surgical Pathology Practice

Overview
Specialty Pathology
Date 2002 Apr 18
PMID 11958660
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Context: The diagnosis of prostate adenocarcinoma in needle core biopsy specimens is based on multiple diagnostic criteria and supportive features, most of which have been defined mainly from observations in transurethral resection and prostatectomy specimens. There is little information on the frequency with which diagnostic and supportive features of prostate cancer occur within benign glands. The few reports dealing with diagnostic criteria of cancer in needle biopsies have been largely confined to analysis of selected cases that posed particular diagnostic difficulty.

Objective: To analyze the frequency with which numerous diagnostic or supportive features of prostate cancer occur in an unselected, consecutively performed series of 18-gauge prostate needle biopsy specimens.

Design: Two hundred fifty consecutive 18-gauge prostate needle biopsy specimens (150 malignant and 100 benign) were evaluated, using hematoxylin-eosin-stained histologic sections.

Results: The frequency of the histologic features in malignant and benign glands was as follows: prominent nucleoli (94% and 25% of malignant and benign specimens, respectively), marginated nucleoli (88% and 7%), multiple nucleoli (64% and 0%), blue-tinged mucinous secretions (52% and 0%), intraluminal crystalloids (40.6% and 1%), intraluminal amorphous eosinophilic material (86.7% and 2%), collagenous micronodules (2% and 0%), glomerulations (15.3% and 0%), perineural invasion (22% and 0%), retraction clefting (38.6% and 7%), and invasion of fat (0.7% and 0%).

Conclusions: Since not all diagnostic or supportive features of cancer are evident in any single case of cancer, particularly in needle biopsy specimens in which sampling is limited, awareness of these data would be helpful in the assessment of small foci of atypical glands being considered for cancer.

Citing Articles

The importance of histomorphological features and ERG expression in the diagnosis of malignancy in cases with atypical small acinar proliferation.

Teoman G, Livaoglu A, Kucuk H, Murtezaoglu A J Pathol Transl Med. 2024; 58(3):134-140.

PMID: 38766739 PMC: 11106607. DOI: 10.4132/jptm.2024.03.18.


Diagnostic utility of immunohistochemical markers alpha methyl acyl coA racemase (AMACR) and Ets related gene (ERG) in prostate cancer.

Stephen N, Badhe B Int J Clin Exp Pathol. 2022; 15(9):364-372.

PMID: 36237639 PMC: 9547992.


Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes.

Ning S, Zhao J, Lombard A, DAbronzo L, Leslie A, Sharifi M Commun Med (Lond). 2022; 2:118.

PMID: 36159187 PMC: 9492734. DOI: 10.1038/s43856-022-00182-9.


Comparison of Immunohistochemistry Expression of CK7, HMWK and PSA in High-Grade Prostatic Adenocarcinoma and Bladder Transitional Cell Carcinoma.

Gheitasi R, Sadeghi E, Jafari M Iran J Pathol. 2021; 16(1):33-39.

PMID: 33391378 PMC: 7691713. DOI: 10.30699/ijp.2020.123998.2353.


Neuroendocrine and Aggressive-Variant Prostate Cancer.

Spetsieris N, Boukovala M, Patsakis G, Alafis I, Efstathiou E Cancers (Basel). 2020; 12(12).

PMID: 33339136 PMC: 7765615. DOI: 10.3390/cancers12123792.